Drug Profile
Lentinan oral - GlycaNova
Alternative Names: MM-10-001Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator GlycaNova
- Class Antineoplastics; Antivirals; Beta Glucans
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Lung cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Lung-cancer(In volunteers) in Norway (PO, Powder)
- 16 Jul 2016 No recent reports of development identified for phase-I development in Lung-cancer(Late-stage disease) in USA (PO, Powder)